Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up.

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM.

Am J Psychiatry. 2016 Feb 12:appiajp201515081045. [Epub ahead of print]

PMID:
26869248
2.

Description and prediction of the income status of borderline patients over 10   years of prospective follow-up.

Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC.

Personal Ment Health. 2016 Feb 11. doi: 10.1002/pmh.1331. [Epub ahead of print]

PMID:
26864557
3.

Prevalence and course of sexual relationship difficulties in recovered and non-recovered patients with borderline personality disorder over 16 years of prospective follow-up.

Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC.

Personal Ment Health. 2016 Feb 11. doi: 10.1002/pmh.1327. [Epub ahead of print]

PMID:
26864454
4.

Quetiapine's effect on the SCL-90-R domains in patients with borderline personality disorder.

Lee SS, Allen J, Black DW, Zanarini MC, Schulz SC.

Ann Clin Psychiatry. 2016 Feb;28(1):4-10.

PMID:
26855980
5.

Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder.

Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM.

Personal Ment Health. 2015 Nov;9(4):243-9. doi: 10.1002/pmh.1302. Epub 2015 Jul 14.

PMID:
26174588
6.

Interactions of borderline personality disorder and anxiety disorders over 10 years.

Keuroghlian AS, Gunderson JG, Pagano ME, Markowitz JC, Ansell EB, Shea MT, Morey LC, Sanislow C, Grilo CM, Stout RL, Zanarini MC, McGlashan TH, Skodol AE.

J Clin Psychiatry. 2015 Nov;76(11):1529-34. doi: 10.4088/JCP.14m09748.

PMID:
26114336
7.

Personality disorder risk factors for suicide attempts over 10 years of follow-up.

Ansell EB, Wright AG, Markowitz JC, Sanislow CA, Hopwood CJ, Zanarini MC, Yen S, Pinto A, McGlashan TH, Grilo CM.

Personal Disord. 2015 Apr;6(2):161-7. doi: 10.1037/per0000089. Epub 2015 Feb 23.

8.

Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up.

Zanarini MC, Frankenburg FR, Bradford Reich D, Harned AL, Fitzmaurice GM.

J Clin Psychopharmacol. 2015 Feb;35(1):63-7. doi: 10.1097/JCP.0000000000000232.

9.

Associations between changes in normal personality traits and borderline personality disorder symptoms over 16 years.

Wright AG, Hopwood CJ, Zanarini MC.

Personal Disord. 2015 Jan;6(1):1-11. doi: 10.1037/per0000092. Epub 2014 Nov 3.

10.

Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study.

Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM.

Psychiatr Serv. 2015 Jan 1;66(1):15-20. doi: 10.1176/appi.ps.201400055. Epub 2014 Oct 31.

11.

Familial aggregation of candidate phenotypes for borderline personality disorder.

Ruocco AC, Hudson JI, Zanarini MC, Gunderson JG.

Personal Disord. 2015 Jan;6(1):75-80. doi: 10.1037/per0000079. Epub 2014 Jul 21.

12.

Pain in patients with borderline personality disorder.

Biskin RS, Frankenburg FR, Fitzmaurice GM, Zanarini MC.

Personal Ment Health. 2014 Aug;8(3):218-27. doi: 10.1002/pmh.1265. Epub 2014 Jul 15.

13.

Interactions of borderline personality disorder and mood disorders over 10 years.

Gunderson JG, Stout RL, Shea MT, Grilo CM, Markowitz JC, Morey LC, Sanislow C, Yen S, Zanarini MC, Keuroghlian AS, McGlashan TH, Skodol AE.

J Clin Psychiatry. 2014 Aug;75(8):829-34. doi: 10.4088/JCP.13m08972.

PMID:
25007118
14.

Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.

Black DW, Zanarini MC, Romine A, Shaw M, Allen J, Schulz SC.

Am J Psychiatry. 2014 Nov 1;171(11):1174-82. doi: 10.1176/appi.ajp.2014.13101348.

PMID:
24968985
15.

The course of marriage/sustained cohabitation and parenthood among borderline patients followed prospectively for 16 years.

Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM.

J Pers Disord. 2015 Feb;29(1):62-70. doi: 10.1521/pedi_2014_28_147. Epub 2014 Jun 25.

16.

Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up.

Zanarini MC, Frankenburg FR, Fitzmaurice GM.

J Pers Disord. 2014 Dec;28(6):767-77. doi: 10.1521/pedi_2014_28_141.

17.

Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder.

Ha C, Balderas JC, Zanarini MC, Oldham J, Sharp C.

J Clin Psychiatry. 2014 May;75(5):e457-64. doi: 10.4088/JCP.13m08696.

PMID:
24922498
18.

Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.

Martinho E Jr, Fitzmaurice GM, Frankenburg FR, Zanarini MC.

J Clin Psychopharmacol. 2014 Aug;34(4):499-503. doi: 10.1097/JCP.0000000000000132.

19.

Comparison of affective instability in borderline personality disorder and bipolar disorder using a self-report measure.

Reich DB, Zanarini MC, Hopwood CJ, Thomas KM, Fitzmaurice GM.

Personal Ment Health. 2014 May;8(2):143-50. doi: 10.1002/pmh.1247. Epub 2013 Oct 10.

PMID:
24700737
20.

The 16-year course of shame and its risk factors in patients with borderline personality disorder.

Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC.

Personal Ment Health. 2014 Aug;8(3):169-77. doi: 10.1002/pmh.1258. Epub 2014 Mar 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk